BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20397911)

  • 1. Making gene therapy for osteosarcoma a reality.
    Broadhead ML; Clark JC; Choong PF; Dass CR
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):477-80. PubMed ID: 20397911
    [No Abstract]   [Full Text] [Related]  

  • 2. Bridging the gap between experimental animals and humans in osteosarcoma.
    Withrow SJ; Khanna C
    Cancer Treat Res; 2009; 152():439-46. PubMed ID: 20213406
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for osteosarcoma: steps towards clinical studies.
    Dass CR; Choong PF
    J Pharm Pharmacol; 2008 Apr; 60(4):405-13. PubMed ID: 18380911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor metastasis].
    Sekiguchi M
    Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):511-28. PubMed ID: 8336071
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy.
    Seto M; Yamazaki T; Sonoda J; Matsumine A; Shinto Y; Uchida A
    Oncol Rep; 2002; 9(2):337-40. PubMed ID: 11836603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
    Lamoureux F; Trichet V; Chipoy C; Blanchard F; Gouin F; Redini F
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):169-81. PubMed ID: 17288528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma: basic science and clinical implications.
    Hayden JB; Hoang BH
    Orthop Clin North Am; 2006 Jan; 37(1):1-7. PubMed ID: 16311106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
    Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
    Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
    Benjamin R; Helman L; Meyers P; Reaman G
    Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma model.
    Liebau C; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Merk H; Wolfram N; Baltzer AW
    Anticancer Res; 2004; 24(5A):2861-7. PubMed ID: 15517889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
    Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
    Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rIL-18 triggered gene therapy based on a transduction with the IL-12 plasmid: a new option as immuno-therapy for osteosarcoma?
    Liebau C; Merk H; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Baltzer AW
    Anticancer Res; 2002; 22(5):2559-65. PubMed ID: 12529964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines.
    Chang B; Punj V; Shindo M; Chaudhary PM
    Cancer Gene Ther; 2007 Nov; 14(11):927-33. PubMed ID: 17693991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma.
    Qiao B; Shui W; Cai L; Guo S; Jiang D
    Drug Des Devel Ther; 2015; 9():969-76. PubMed ID: 25733814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
    Ek ET; Dass CR; Contreras KG; Choong PF
    Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus and adenovirus receptor expression on primary osteosarcoma specimens and implications for gene therapy with recombinant adenoviruses.
    Graat HC; Wuisman PI; van Beusechem VW; Carette JE; Gerritsen WR; Bras J; Schaap GR; Kaspers GJ; Ogose A; Gu W; Kawashima H; Hotta T
    Clin Cancer Res; 2005 Mar; 11(6):2445-7; author reply 2447-8. PubMed ID: 15788696
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Osteosarcoma.
    Enneking WF
    Clin Orthop Relat Res; 1975 Sep; (111):2-4. PubMed ID: 1057463
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems in the interpretation of results of treatment for osteosarcoma.
    Dahlin DC
    Mayo Clin Proc; 1979 Sep; 54(9):621-2. PubMed ID: 288961
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
    Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
    Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.